Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Radiopharmaceuticals conjugate toxic radioactive isotopes to targeting ligands, offering similar innovation potential to ADCs and also attracting growing buyer interest and investment
Pharmacokinetic Notes: Short-acting GLP-1 RAs (exenatide BID, lixisenatide) primarily affect postprandial glucose and tend to cause more gastrointestinal side effects initially due to rapid high peaks
It acts as the ultimate electron donor for the glutaredoxin system, which activates ribonucleotide reductase (RNR) , the rate-limiting enzyme responsible for converting ribonucleotides into the deoxyribonucleotides (dNTPs) needed for DNA replication
But as demand has grown, so has the question of how best to take it
US$ 28.30
US$ 25.56
US$ 23.39
US$ 21.99
